Theolytics Company

Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies.
Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies. The company was formed in 2017 to drive the development of a pipeline of novel clinical trial candidates, and is led by a team that combines over 40 years of experience in oncolytic virus development. The company uses an adenovirus platform to develop targeted, self-amplifying therapeutic agents, and aims to deliver innovative cancer care to millions of people in need worldwide.
Technology: Drug Discovery
Industry: Preventive Medicine
Headquarters: Oxford, Oxfordshire, United Kingdom
Founded Date: 2017
Employees Number: 1-10
Funding Status: Seed

Visit Website
enquiry@theolytics.com
Register and Claim Ownership